Luminex logo

LMNX - Luminex News Story

$36.71 0.0  0.0%

Last Trade - 22/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.15bn
Revenue £301.7m
Position in Universe 2376th / 6857

BRIEF-Luminex Receives BARDA Contract To Support Development Of Second, Rapid SARS-CoV-2 Test

Tue 31st March, 2020 12:46pm
March 31 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX RECEIVES BARDA CONTRACT TO SUPPORT DEVELOPMENT OF
SECOND, RAPID SARS-COV-2 TEST
    * LUMINEX CORP - ARIES SARS-COV-2 ASSAY WILL BE SUBMITTED
FOR EUA
LATER THIS WEEK
    * LUMINEX CORP - INTENDS TO PRICE ARIES SARS-COV-2 ASSAY
BELOW
CURRENT GOVERNMENT REIMBURSEMENT LEVELS

Source text for Eikon:  ID:nPn1DrHzPa 
Further company coverage:  LMNX.O 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.